Company Profiles

driven by the PitchBook Platform

Polyphor

Description

Developer of macrocycle drugs intended to address antibiotic resistance and rare pulmonary diseases. The company is developing a pre-clinical and clinical portfolio of own drug candidates in important disease areas. In addition, its EMfinder and MacroFinder macrocycle technologies are used in collaborative drug discovery projects with Pharma companies focusing focuses on the therapeutic benefit to the patient.

1996

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$10M

Latest Deal Amount

$10M

Total Amount Raised

Description

Developer of macrocycle drugs intended to address antibiotic resistance and rare pulmonary diseases. The company is developing a pre-clinical and clinical portfolio of own drug candidates in important disease areas. In addition, its EMfinder and MacroFinder macrocycle technologies are used in collaborative drug discovery projects with Pharma companies focusing focuses on the therapeutic benefit to the patient.

Website:

www.polyphor.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Discovery Tools (Healthcare)

Primary Office

Hegenheimermattweg 125 4123 AllschwilSwitzerland +41 (0)61 567 1600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Polyphor's full profile, request a free trial.

Polyphor Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Polyphor Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BachemCorporationMinority000 0000000 0000
BioBacAngel GroupMinority000 0000000 0000
BioMedPartnersVenture CapitalMinority000 0000000 0000
Christoph RentschAngel (individual)Minority000 0000000 0000
Core Capital PartnersVenture CapitalMinority000 0000000 0000
Bachem Corporation
BioBac Angel Group
BioMedPartners Venture Capital
Christoph Rentsch Angel (individual)
Core Capital Partners Venture Capital

Polyphor Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Giacomo Di NepiChief Executive Officer
Kalina ScottChief Financial Officer
Debra Barker MDChief Medical & Development Officer
Daniel Obrecht Ph.DChief Scientific Officer & Co-Founder
Helmut Kessmann Ph.DHead, Business Development
Giacomo Di Nepi Chief Executive Officer
Kalina Scott Chief Financial Officer
Debra Barker MD Chief Medical & Development Officer
Daniel Obrecht Ph.D Chief Scientific Officer & Co-Founder
Helmut Kessmann Ph.D Head, Business Development

Polyphor Board Members (14)

NameRepresentingRoleSinceContact
Info
Andreas Wallnöfer Ph.DBioMedPartnersPartner000 0000
Anja König Ph.DNovartis Venture FundCo-Managing Director000 0000
Bernard BollagSelfBoard Member000 0000
Jack BaldwinSelfBoard Member000 0000
Jean-Jacques Garaud MDSelfBoard Member000 0000
Andreas Wallnöfer Ph.D Partner BioMedPartners
Anja König Ph.D Co-Managing Director Novartis Venture Fund
Bernard Bollag Board Member Self
Jack Baldwin Board Member Self
Jean-Jacques Garaud MD Board Member Self
Request full access to PitchBook